---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-000410"
form_type: "8-K"
ticker: "LEXX"
cik: "0001348362"
company_name: "Lexaria Bioscience Corp."
filed_at: "2024-03-15T23:59:59+00:00"
generated_at: "2026-06-04T16:54:03.208333+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexaria Bioscience appoints Nelson Cabatuan as CFO effective March 14, 2024

## Summary
- Nelson Cabatuan, age 46, replaces temporary outsourced CFO services from NOW CFO.
- Base annual salary of US$198,000 with agreed annual increases of US$12,000 for first two years.
- Option grant of up to 200,000 common shares vested over three years; performance bonuses up to 35-50% of base.
- Exit compensation: upon sale of affiliate, 0.5%-1.0% of gross sale value; change-of-control triggers 12-14 months base salary.
- Cabatuan brings over 15 years biotech finance experience; previously SVP at Rain Oncology and VP at Rigel Pharmaceuticals.

## SEC filing metadata
- accession: 0001640334-24-000410
- form_type: 8-K
- ticker: LEXX
- cik: 0001348362
- company_name: Lexaria Bioscience Corp.
- filed_at: 2024-03-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000410/0001640334-24-000410-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000410/lxrp_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-000410
- JSON: https://secwatch.observer/filing/0001640334-24-000410.json
- Plain text: https://secwatch.observer/filing/0001640334-24-000410.txt

## Key facts
- Executive change
  Nelson Cabatuan was appointed as Chief Financial Officer at Lexaria Bioscience Corp..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: Effective March 14, 2024, Nelson Cabatuan, age 46, has been appointed to the position of Chief Financial Officer of Lexaria Bioscience Corp.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1348362/000164033424000410/0001640334-24-000410-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.